Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease

JAMA Cardiol. 2022 Jan 1;7(1):112-113. doi: 10.1001/jamacardio.2021.4398.

Authors

Ahmad Hayek¹, Francois Derimay², Thomas Bochaton¹

Affiliations

¹ Cardiac Intensive Care Unit, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France.
² Department of Cardiology and Interventional Cardiology, Hôpital Cardiologique Louis Pradel, Université Claude-Bernard, Inserm UMR 1060, Lyon, France.

PMID: 34705019
DOI: 10.1001/jamacardio.2021.4398

No abstract available

Publication types

Comment

MeSH terms

Biomarkers
Humans
Myocardial Infarction* / diagnosis

Substances

Biomarkers